• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌与胃癌。

Helicobacter pylori and Gastric Cancer.

机构信息

Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, NY, USA.

Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Gastrointest Endosc Clin N Am. 2021 Jul;31(3):451-465. doi: 10.1016/j.giec.2021.03.003.

DOI:10.1016/j.giec.2021.03.003
PMID:34053633
Abstract

Helicobacter pylori is present in approximately one-half of the world's population. There are significant differences in prevalence based on region, age, race/ethnicity, and socioeconomic status. H pylori is the most common cause of infection-related cancers. Studies have demonstrated the relationship between H pylori infection and gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. H pylori has features and enzymatic properties allowing it to survive in the acidic stomach environment, and has specific virulence factors that promote an increased risk of gastric pathology. Eradication of H pylori is first-line therapy for mucosa-associated lymphoid tissue lymphoma and decreases the risk of gastric adenocarcinoma.

摘要

幽门螺杆菌存在于世界上大约一半的人口中。其流行率因地区、年龄、种族/民族和社会经济地位而有显著差异。幽门螺杆菌是感染相关癌症的最常见原因。研究表明,幽门螺杆菌感染与胃腺癌和黏膜相关淋巴组织淋巴瘤之间存在关联。幽门螺杆菌具有在酸性胃环境中生存的特征和酶学特性,并且具有特定的毒力因子,可增加胃病理的风险。根除幽门螺杆菌是黏膜相关淋巴组织淋巴瘤的一线治疗方法,可降低胃腺癌的风险。

相似文献

1
Helicobacter pylori and Gastric Cancer.幽门螺杆菌与胃癌。
Gastrointest Endosc Clin N Am. 2021 Jul;31(3):451-465. doi: 10.1016/j.giec.2021.03.003.
2
Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.幽门螺杆菌阴性的胃黏膜相关淋巴组织淋巴瘤:综述
World J Gastroenterol. 2015 Jul 14;21(26):8014-20. doi: 10.3748/wjg.v21.i26.8014.
3
[Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].[幽门螺杆菌感染及根除治疗对胃黏膜相关淋巴组织淋巴瘤的预后影响]
Korean J Lab Med. 2010 Dec;30(6):547-53. doi: 10.3343/kjlm.2010.30.6.547.
4
[Helicobacter pylori eradication for gastric MALT lymphoma].[幽门螺杆菌根除治疗胃黏膜相关淋巴组织淋巴瘤]
Nihon Rinsho. 2013 Aug;71(8):1424-8.
5
Review article: would eradication of Helicobacter pylori infection reduce the risk of gastric cancer?综述文章:根除幽门螺杆菌感染会降低胃癌风险吗?
Aliment Pharmacol Ther. 2001 Jun;15 Suppl 1:2-5. doi: 10.1046/j.1365-2036.2001.00109.x.
6
[Helicobacter pylori and gastric cancer].[幽门螺杆菌与胃癌]
Rev Gastroenterol Peru. 2008 Jul-Sep;28(3):258-66.
7
Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.幽门螺杆菌根除疗法对幽门螺杆菌阴性且弥漫性胃黏膜相关淋巴组织淋巴瘤患者作为初始治疗有效。
Gut Liver. 2016 Sep 15;10(5):706-13. doi: 10.5009/gnl15510.
8
Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.幽门螺杆菌再次作祟:胃黏膜相关淋巴组织(MALT)淋巴瘤。
Gastroenterol Nurs. 2007 Sep-Oct;30(5):348-54; quiz 355-6. doi: 10.1097/01.SGA.0000296255.16576.e5.
9
Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.综述文章:幽门螺杆菌相关胃黏膜相关淋巴组织淋巴瘤治疗中的常见误区。
Aliment Pharmacol Ther. 2011 Nov;34(9):1047-62. doi: 10.1111/j.1365-2036.2011.04839.x. Epub 2011 Sep 15.
10
Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.采用根除幽门螺杆菌治疗低度恶性胃黏膜相关淋巴组织淋巴瘤。
Vojnosanit Pregl. 2015 May;72(5):431-6. doi: 10.2298/vsp1505431g.

引用本文的文献

1
ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment.ATR-CHK1轴抑制剂在胃癌治疗中的应用
Int J Mol Sci. 2025 Aug 9;26(16):7709. doi: 10.3390/ijms26167709.
2
[Approach to Patients after Successful Eradication of ].[根除成功后对患者的处理方法]。 (你提供的原文似乎不完整,缺少关键内容)
Korean J Helicobacter Up Gastrointest Res. 2023 Mar;23(1):22-27. doi: 10.7704/kjhugr.2023.0019. Epub 2023 Mar 9.
3
The relationship between the eradication of Helicobacter pylori and the occurrence of stomach cancer: an updated meta-analysis and systemic review.
幽门螺杆菌根除与胃癌发生之间的关系:一项更新的荟萃分析和系统评价
BMC Gastroenterol. 2025 Apr 21;25(1):278. doi: 10.1186/s12876-025-03886-z.
4
Unlocking the Therapeutic Potential of Patchouli Leaves: A Comprehensive Review of Phytochemical and Pharmacological Insights.解锁广藿香叶的治疗潜力:植物化学与药理学见解的全面综述
Plants (Basel). 2025 Mar 26;14(7):1034. doi: 10.3390/plants14071034.
5
Correlation between dietary vitamin B2 intake and helicobacter pylori infection in US adults: a cross-sectional study.美国成年人饮食中维生素B2摄入量与幽门螺杆菌感染之间的相关性:一项横断面研究。
J Health Popul Nutr. 2025 Mar 12;44(1):76. doi: 10.1186/s41043-025-00815-4.
6
Nomogram Prediction for Gastric Cancer Development.胃癌发生的列线图预测
Clin Transl Gastroenterol. 2025 May 1;16(5):e00833. doi: 10.14309/ctg.0000000000000833.
7
A Prognostic Riskscore Model Related to Infection in Stomach Adenocarcinoma.一种与胃腺癌感染相关的预后风险评分模型。
Int J Genomics. 2025 Jan 21;2025:5554610. doi: 10.1155/ijog/5554610. eCollection 2025.
8
Expression of Salivary miRNAs, Clinical, and Demographic Features in the Early Detection of Gastric Cancer: A Statistical and Machine Learning Analysis.唾液 microRNAs 的表达、临床和人口统计学特征在胃癌的早期检测中的作用:统计和机器学习分析。
J Gastrointest Cancer. 2024 Nov 9;56(1):15. doi: 10.1007/s12029-024-01136-1.
9
leaves as source of anti- agents.树叶作为抗剂的来源。
Front Pharmacol. 2024 Oct 23;15:1461447. doi: 10.3389/fphar.2024.1461447. eCollection 2024.
10
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer.持续性病原体感染与肿瘤微环境和癌症免疫治疗的相互作用。
Cancer Med. 2024 Sep;13(17):e70154. doi: 10.1002/cam4.70154.